This investigation aims to determine experimentally whether or not ultrasound (US) irradiation is effective in enhancing the in vivo gene expression of NK4 plasmid DNA and suppressing tumor growth. NK4, composed of the NH 2 -terminal hairpin and subsequent four-kringle domains of hepatocyte growth factor (HGF), acts as an HGF-antagonist and angiogenesis inhibitor. Dextran was cationized by introducing spermine to the hydroxyl groups to allow for polyionic complexation with NK4 plasmid DNA. The cationized dextran was additionally modified with poly(ethylene glycol) (PEG) molecules giving PEG engrafted cationized dextran. Significant suppression of tumor growth was observed when PEG engrafted cationized dextran-NK4 plasmid DNA complexes were intravenously injected into mice carrying a subcutaneous Lewis lung carcinoma tumor mass with subsequent US irradiation when compared with the cationized dextran-NK4 plasmid DNA complex and naked NK4 plasmid DNA with or without US irradiation. We conclude that complexation with PEG-engrafted cationized dextran in combination with US irradiation is a promising way to target the NK4 plasmid DNA to the tumor for gene expression.
Introduction
Hepatocyte growth factor (HGF) has been noted as the signal molecule playing an important role in development, morphogenesis, and regeneration of living systems. [1] [2] [3] [4] Recently, some therapeutic trials of angiogenesis induction, 5, 6 chronic fibrotic diseases, [7] [8] [9] and tissue regeneration 10, 11 by HGF have been performed in the laboratory and clinically to demonstrate any potential efficacies. On the other hand, for malignant tumors, HGF plays a definitive role in invasive, angiogenic, and metastatic behavior of cancer cells by way of the c-Met receptor. [12] [13] [14] [15] [16] Therefore, it is expected that inhibition of interaction between HGF and the c-Met receptor should effectively suppress the malignant activity of tumors. Based on this concept, Date et al. 17 prepared an antagonist for HGF. The antagonist (NK4) is composed of the NH 2 -terminal hairpin domain and the subsequent four kringle domains of a-subunit of HGF. NK4 binds to the c-Met/HGF receptor but does not induce tyrosine phosphorylation of c-Met. 17 NK4 competitively inhibits some biological events driven by the HGF-Met receptor binding, including the invasion and metastasis of distinct types of tumor cells. 17, 18 Moreover, NK4 has antiangiogenic activity which is independent of its activity as an HGF antagonist. 19 The recombinant protein of NK4 has been used in tumor animal models to demonstrate in vivo therapeutic feasibility and the blocking effect on HGF functions. [18] [19] [20] In addition, antitumor effects of stable expression of NK4 in cancer cells and the recombinant adenovirus-mediated gene expression of NK4 have been reported. [21] [22] [23] [24] [25] Recently, ultrasound (US) irradiation has been widely applied to therapeutic, operative, and diagnostic procedures in clinical medicine. [26] [27] [28] Such physical therapy is popular since US acts on cells and tissues by various thermal or non-thermal mechanisms, sometimes promoting wound healing. The main objective of US therapy is to speed up the healing process of hard or soft tissue injuries. In addition, US has some practical advantages, such as clinical accessibility, low cost, and safety, in therapeutic usage. US can be described as a propagating pressure wave or sound wave capable of transferring mechanical energy into various body tissues. The energy is absorbed, propagated or reflected depending on the frequency and tissue type. It has been reported that US-induced mechanical perturbations serve as extracellular stimuli to osteogenic cells. 29 The positive effects of US on bone fracture healing have also been reported. 30 The release profile of drugs from polymeric matrices can be regulated using US, 31 while several researchers have reported the US-enhanced transdermal permeation of drugs. [32] [33] [34] The transfection efficiency of plasmid DNA in vitro and in vivo was also found to be enhanced by US irradiation. [35] [36] [37] Anwer et al. 38 have demonstrated that the impact of a localized application of US on gene transfer to primary tumors following systemic administration of cationic lipid-based transfection complexes results in a significant increase in gene transfer to the tumor with no increase observed in other tissues.
This study was undertaken to investigate the feasibility of US irradiation for enhancement of the gene expression of NK4 plasmid DNA in the tumor. Dextran was selected as a nonviral vector of NK4 plasmid DNA. Dextran is a water-soluble polysaccharide with multiple hydroxyl groups amenable to chemical modification, and has low immunogenicity and a long history of clinical use and pharmaceutical applications demonstrating the feasibility of its use in passive tumor targeting of drugs. [39] [40] [41] Our previous study demonstrated that dextran significantly enhanced in vitro and in vivo gene trasnfection. 42 To give the dextran a cationized charge, which is necessary for the formation of polyion complexes with plasmid DNA, spermine was introduced to the hydroxyl groups of dextran. The cationized dextran was then reacted with poly(ethylene glycol) (PEG) and mixed with NK4 plasmid DNA in aqueous solution. Following intravenous injection of complexes of PEG-free or PEG engrafted cationized dextran and NK4 plasmid DNA, tumors were exposed to US, and then the gene expression in the tumor was compared with that after the injection of the complex alone, to assess the tumor targetability from the viewpoint of the gene expression level.
Materials and methods

Materials
Dextran
(weight-average molecular weight (Mw) ¼ 75 000), 2,4,6-trinitrobenzenesulfonic acid (TNBS), and b-alanine were purchased from Nakalai Tesque Inc., Kyoto, Japan and were used as received. PEG with succinimidyl succinate and methoxy residues on each terminal (MEC-PEG, Mw ¼ 5250) was kindly supplied by Nihon Oil Fat Co., Tokyo, Japan and was used as received. Spermine was purchased from Wako Pure Chemical Industries, Ltd., Osaka, Japan and was used as received. The coupling agent N,N 0 -carbonyldiimidazole (CDI) and a DNA Mw standard marker (1 kb DNA Ladder) were obtained from Dojindo Laboratories, Kumamoto and Takara Shuzo Co. Ltd., Shiga, Japan, respectively. Rhodamine B isothiocyanate (RITC) was obtained from Sigma-Aldrich Japan K.K., Tokyo, Japan.
Preparation of plasmid DNA pCMV-LacZ and pCMV-NK4 were used in this study. The pCMV-LacZ contains a reporter gene encoding a cytomegalovirus (CMV) promoter inserted at the upstream region of the sequence coding the LacZ. The pCMV-NK4 contains an expression vector consisting of a coding sequence of NK4 gene segments and a CMV promoter inserted in the downstream region. The plasmid DNA was amplified in a transformant of Escherechia coli bacteria and isolated from the bacteria by Qiagen Maxi kit-25 (Qiagen K.K., Tokyo, Japan). The absorbance ratio at the wavelength of 260-28 nm to assess the purity of plasmid DNA was measured to be between 1.8 and 2.0.
Preparation of cationized dextran
Cationized dextran was prepared by introduction of spermine at the hydroxyl groups of dextran based on the conventional CDI method. 43 Briefly, 20 mg of spermine and 10 mg of CDI were added to 50 ml of dehydrated dimethyl sulfoxide (dDMSO) containing 10 mg of dextran. The reaction solution was agitated at 251C for 20 h to introduce the spermine residue to the hydroxyl groups of dextran, followed by dialysis against double-distilled water (DDW) for 2 days and freezedrying to obtain the cationized dextran. When determined by the trinitrobenzene sulfonate (TNBS) method, 44 based on the calibration curve prepared using b-alanine, the percentage of amino groups introduced into dextran was 37.8 mol/mol hydroxyl groups of dextran. A schematic preparation of cationized dextran is shown in Figure 1 .
Preparation of PEG engrafted cationized dextran and complexation with plasmid DNA PEG engrafted cationized dextran was prepared by chemical introduction of MEC-PEG at the amine group of the spermine residue in cationized dextran. Briefly, 20 mg of MEC-PEG was added to 10 ml of dDMSO containing 10 mg of cationized dextran. The reaction solution was agitated at 251C for 16 h to introduce MEC-PEG to the amine group of cationized dextran, followed by dialysis against DDW for 2 days and freeze-drying to obtain PEG engrafted cationized dextran. When determined by the TNBS method, based on the calibration curve prepared using b-alanine, the percentage of PEG engrafted onto cationized dextran was 20.6 mol/mol amino groups of dextran spermine. A schematic for the preparation of PEG engrafted cationized dextran is shown in Figure 2 .
Complexation of PEG-free or PEG engrafted cationized dextran with plasmid DNA was performed by a simple mixing of the two materials at various charge ratios in aqueous solution. Briefly, 150 ml of 0.1 M phosphate-buffered saline solution (PBS, pH 7.4) containing 10, 50, 100, 200, 300, 400, and 500 mg of cationized dextran, with or without PEG engrafted, was added to the same volume of PBS containing 10 mg of plasmid DNA. The solution was gently agitated at 371C for 30 min to form cationized dextran-plasmid DNA complexes with or without PEG engrafted. Since the charge ratio (N/P) is presented as the molar mixing ratio of cationized dextran nitrogen to plasmid DNA phosphate, its value was 1, 2, 3, 4, 5, 6 or 8 for the complexation of cationized dextran and plasmid DNA.
Electrophoresis of cationized dextran-plasmid DNA complexes with or without PEG engrafted Cationized dextran-plasmid DNA complexes with or without PEG engrafted were prepared at various N/P ratios according to the procedure described above. The complex samples were electrophoresed for 40 min at 100 V in 0.75 wt% of agarose gel using 45 mM Trisborate and 1 mM EDTA buffer (pH 8.0). The gel was stained with 0.5 mg/ml ethidium bromide solution for 30 min to visualize the localization of plasmid DNA with a Gel Doc 2000 (Bio-Rad Laboratories, Tokyo, Japan).
Measurement of dynamic light scattering and electrophoretic light scattering
The complexes of PEG-free or PEG engrafted cationized dextran and plasmid DNA at various N/P ratios were prepared by a similar procedure to that described above. Each solution was filtered through a 0.45 mm filter (Millex-HV, Millipore) prior to mixing. The mixed plasmid DNA and cationized dextran with or without PEG engrafted in aqueous solution (PBS, pH 7.4) was placed in a dynamic light scattering (DLS) cell and DLS measurement was performed using a DLS-DPA-60HD instrument (Otsuka Electronic Co. Ltd., Osaka, Japan) equipped with an Ar þ laser at a detection angle of 901 at 371C for 30 min and performed three times for each sample. The corresponding hydrodynamic radius, R s , can be calculated from Einstein-Stokes' equation: R s ¼ kT/3pZD, where k is the Boltzman constant, T is the absolute temperature, Z is the solvent viscosity, and D is the Ultrasound enhances suppression of tumor growth H Hosseinkhani et al translational diffusion coefficient obtained from the DLS measurements. In this study, the autocorrelation function of samples was analyzed based on the cumulants method and the R s value was automatically calculated by the DLS computer software and expressed as the apparent molecular size of each of the samples. ELS measurement was carried on an ELS-7000AS instrument (Otsuka Electronic Co. Ltd., Osaka, Japan) for mixed plasmid DNA and cationized dextran with or without PEG engrafted in PBS at 371C and with an electric field strength of 100 V/cm. The ELS measurement was performed three times for each sample. The zeta potential (z) was automatically calculated using the Smoluchouski equation based on the electrophoretic mobility measured z ¼ 4pZu/e, where Z and e are the viscosity and the dielectric constant of solvent, respectively.
In vivo experiments
Lewis lung carcinoma (LLC) cells were cultured in the Dulbecco's modified Eagle's medium supplemented with 100 U/l streptomycin, 100 mg/l penicillin, and 10 vol% fetal calf serum for proliferation. The LLC cells were subcutaneously inoculated into the back subcutis of 6-to 8-week-old male C57BL/6 mice (Japan SLC Inc., Hamamatsu, Japan) at the concentration of 1 Â 10 7 cells/ 400 ml serum-free medium. After 4 days tumor inoculation, C57BL/6 mice carrying a tumor mass of 5 mm average diameter on the back subcutis received an intravenous injection of PBS, naked NK4 plasmid DNA, cationized dextran-NK4 plasmid DNA complex, and PEG engrafted cationized dextran-NK4 plasmid DNA complex in a volume of 200 ml. At 2 h after intravenous injection, of the complexes or other agents to the mice, the surface of the tumor was exposed to US for 2 min at the intensity of 2 W/cm 2 , a frequency of 3 MHz, and a 10% duty cycle. The US machine used was an InterTron R 6100 plane transducer US (Williams Healthcare System, Nihon Medix, Tokyo, Japan) and the US probe was attached percutaneously to the tumor mass with an US gel (Parker Laboratories Inc.).
The number of dead mice was noted every day for preparation of the survival curve. The size of the tumor mass was measured using a dial caliper to calculate the tumor volume and using the formula width 2 Â length Â 0.52 (20-25 mice/group). 19 Mice were killed by cervical dislocation, and their tumor and organs were sampled at 1, 3, 5, 7, 10, 14, 21, and 28 days later, washed with PBS, frozen in liquid nitrogen, and stored at À851C to await assay of their level of gene expression. The number of mice for each experiment at each sampling time was 6. All the animal experiments were carried out according to the Institutional Guidance of Kyoto University on Animal Experimentation.
Assay method of gene expression
As an assay of gene expression in the tumor and organs, the gene expression of NK4 was measured using an HGF EIA kit (Institute of Immunology Co., Ltd., Tokyo, Japan). Briefly, the tumor and organ samples were immersed and homogenized in a lysis buffer (Institute of Immunology Co., Ltd., Tokyo, Japan) at the buffer volume (ml)/sample weight (mg) ratio of 4:1 in order to normalize the influence of weight variance on the assay. The sample lysate (0.2 ml) was transferred to a centrifuge tube and centrifuged at 15 000 g at 41C for 15 min. The supernatant (50 ml) and serum were applied to the wells of the HGF EIA kit. One sample was taken per mouse per experiment. Each experiment was performed for six mice independently unless noted otherwise.
Tissue staining
The tumor samples were fixed by mixed 2 wt% glutaraldehyde and 20 wt% formaldehyde aqueous solution for 30 min. After washing with PBS 3 times, the fixed samples were placed in 25 ml of staining solution comprised of 1.25 ml of X-gal (20 mg/ml in dimethylformamide), 250 ml of 5 mM potassium ferricyanide, 250 ml of 5 mM potassium ferrocyanide, 250 ml of 2 mM MgCl 2 , and 23 ml of PBS. Following incubation at 371C for 2 h, the sample was macroscopically viewed to check the area of X-gal staining.
Fluorescent microscopic observation
For the fluorescent labeling of plasmid DNA, 1 mg/ml of the pCMV-LacZ and 1 mg/ml of RITC were mixed in 0.2 M sodium carbonate-buffered solution (pH 9.7) at 41C for 12 h. The reaction mixture was then subjected to gel filtration using a PD 10 column (Amersham Pharmacia Biotech K.K., Tokyo, Japan) to separate the unreacted RITC from the RITC-labeled pCMV-LacZ, followed by ethanol precipitation for collection.
An aqueous solution of 2 mg/ml RITC-labeled plasmid DNA (50 ml) was mixed with 40 ml of cationized dextran at the N/P molar ratio of 5 to form the complex of PEG engrafted cationized dextran and plasmid DNA. After intravenous injection of PBS, naked RITClabeled pCMV-LacZ, cationized dextran-RITC-labeled pCMV-LacZ complex, and PEG engrafted cationized dextran-RITC-labeled pCMV-LacZ complex with or without the subsequent US irradiation, the tumor was removed 5 days later and embedded in Tissue-Tek (OCT Compound, Miles Inc.). The cryosections (5 mm thickness) of the tumor samples were prepared for fluorescence viewing of the localization of plasmid DNA using an Olympus AX-80 fluorescence microscope equipped with an Olympus DP50 digital camera (KS Olympus, Tokyo, Japan).
Statistical analysis
All the data were analyzed statistically to express the mean7the standard deviation (s.d.) of the mean. Student's t-test was performed and Po0.05 was accepted to be statistically significant.
Results
Preparation and characterization of PEG engrafted cationized dextran and its complexation with plasmid DNA Figure 3 shows the apparent molecular size and surface charge of NK4 plasmid DNA complexed cationized dextran with or without PEG engrafted. Complexation with cationized dextran caused the apparent molecular size of plasmid DNA to be reduced to about 250 nm. However, PEG engrafted cationized dextran did not change the apparent molecular size of the plasmid DNA complexes and the size was similar to that of plasmid DNA complexes with PEG-free cationized dextran. It is clear that complexation with PEG engrafted cationized dextran reduces the charge of plasmid DNA to nearly zero. Our previous study revealed that significantly enhanced gene expression of LacZ plasmid DNA in the tumor of mice after intravenous injection of the PEG engrafted cationized dextran-plasmid DNA complex was observed at the N/P ratio of 5. 45 Based on those results, the N/P ratio of 5 was used in this study. Figure 4 shows the electrophoretic patterns for NK4 plasmid DNA complexed cationized dextran with or without PEG engrafted at different N/P molar ratios. Unmodified dextran induced electrophoretic migration of NK4 plasmid DNA, but did not induce retardation. The migration of NK4 plasmid DNA was retarded as the N/P molar ratio increased, but was not observed at ratios higher than a certain value. Complexation with PEG engrafted cationized dextran affected greatly the electrophoresis migration pattern of NK4 plasmid DNA.
Effect of US irradiation on the in vivo gene expression of tumor and organs of mice following intravenous injection of cationized dextran-NK4 plasmid DNA complexes with or without PEG engrafted Figure 5 shows the time dependency of the amount of NK4 protein expression in the primary tumor tissue of 
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tumor-bearing mice after intravenous injection of PBS, naked NK4 plasmid DNA, cationized dextran-NK4 plasmid DNA complex, and PEG engrafted cationized dextran-NK4 plasmid DNA complex with or without US irradiation. A significantly enhanced level of gene expression was observed in the tumors of mice receiving the injection of the PEG engrafted cationized dextran-NK4 plasmid DNA complex with US irradiation, in contrast to the other agents with or without US irradiation. The NK4 concentration in the tumor increased with time until a maximum level on day 5 and thereafter decreased gradually. Conversely and irrespective of US irradiation, neither naked NK4 plasmid DNA nor cationized dextran-NK4 plasmid DNA complex enhanced the gene expression in the tumor, and the level of gene expression was similar to that of the PBS-injected control. In addition, gene expression was not observed in other internal organs such as the liver, kidney, heart, lung, and spleen (data not shown). A LacZ plasmid DNA was used to clarify the expression site. Figure 6 shows the X-Gal staining of tumor following the intravenous injection of PEG engrafted cationized dextran-plasmid DNA complex with or without US irradiation. Only slight blue coloring was imparted by the injection of PEG engrafted cationized dextran-plasmid DNA complex alone. The extent of the colored area increased with increase in US exposure duration, while it also depended on the interval time between complex injection and US irradiation. Figure 7 shows the fluorescent microscopic photographs of tumor following the intravenous injection of PBS, naked LacZ plasmid DNA, cationized dextranLacZ plasmid DNA complex, and PEG engrafted The dose of plasmid DNA used was 10 mg. *Po0.05: significant against the NK4 protein detected of mice after injection of PBS with or without US irradiation on the corresponding day. wPo0.05: significant against the NK4 protein detected of mice after injection of naked NK4 plasmid DNA with or without US irradiation on the corresponding day. zPo0.05: significant against the NK4 protein detected of mice after injection of cationized dextran-NK4 plasmid DNA complex with or without US irradiation on the corresponding day. Effect of US irradiation on the prolonged survival and suppression of tumor growth by cationized dextran-NK4 plasmid DNA complexes with or without PEG engrafted Figure 8 shows the survival curve of tumor-bearing mice after intravenous injection of PBS, naked NK4 plasmid (1), naked RITC-labeled LacZ plasmid DNA (2), cationized dextran-RITC-labeled LacZ plasmid DNA complex (3), and PEG engrafted cationized dextran-RITC-labeled LacZ plasmid DNA complex (4) with or without US irradiation. US irradiation was performed 120 min after injection of the complex (irradiation time period ¼ 2 min, intensity ¼ 2 W/cm 2 , frequency ¼ 3 MHz, and duty cycle ¼ 10%). The dose of plasmid DNA used is 10 mg.
Ultrasound enhances suppression of tumor growth H Hosseinkhani et al DNA, cationized dextran-NK4 plasmid DNA complex, and PEG engrafted cationized dextran-NK4 plasmid DNA complex with or without US irradiation. When the mice were injected with PBS, naked NK4 plasmid DNA solution, and cationized dextran-NK4 plasmid DNA complex with or without US irradiation, all the mice died within 26 days. On the other hand, the injection of PEG engrafted cationized dextran-NK4 plasmid DNA complex with US irradiation significantly prolonged the survival time period of mice. Figure 9 shows changes in primary tumor growth after intravenous injection of PBS, naked NK4 plasmid DNA, cationized dextran-NK4 plasmid DNA complex, and PEG engrafted cationized dextran-NK4 plasmid DNA complex with or without US irradiation. Increase in the tumor volume was significantly suppressed by the injection of PEG engrafted cationized dextran-NK4 plasmid DNA complex with US irradiation, in marked contrast to other agents.
Discussion
The present study clearly demonstrates the efficacy of US irradiation on enhancement of in vivo gene expression in the tumor by PEG engrafted cationized dextran as a nonviral gene carrier. The advantages of the application of low-intensity US are the low invasiveness and cost, easy applicability to the body, and the focused nature of the method.
The physical and colloidal parameters of transfection complexes, such as particle size, charge, and stability, are critical factors contributing to the biodistribution and expression profiles of plasmid DNA complexes. The parameters should be considered for design of gene delivery carriers for in vivo applications. It is well known that the positively charged gene carriers are prone to nonspecifically interact with a variety of negatively charged components in the blood, extracellular matrix, and nontarget cells because of electrostatic forces. 46 These nonspecific interactions result in degradation of the carriers and the nonspecific cell uptake, which cause the in vivo destabilization of plasmid DNA-carrier complexes. Mixing of plasmid DNA with the PEGfree cationized dextran did not result in gene expression in the tumor. This may be due to electrostatic interactions with negatively charged blood cells and components that prevent the plasmid DNA from reaching the tumor tissue ( Figure 5 ). From the viewpoint of tumor targeting, the complex charge should be neutral or negative to reduce or negate interaction with the blood cells and components. In addition, the compact size of the complex is advantageous in terms of passive targeting of the complex at the tumor. It has been reported that the size of substances injected intravenously is one of the key factors contributing to passive accumulation in the tumor. 47 An enhanced level of tumor gene expression caused by the PEG engrafted cationized dextranplasmid DNA complex is due to enhanced tumor accumulation. It is conceivable that the spermine residue can compact the molecular size of plasmid DNA and, in additional, PEG protects the plasmid DNA complex from interaction with biological substances and from enzymatic degradation, resulting in a more efficient delivery of the complex. 48 have demonstrated that the gene expression of plasmid DNA complexed with a cationic liposome was enhanced by US exposure. Therefore, this is an important strategy for the exploitation of US irradiation for the enhancement of plasmid DNA transfection by nonviral vectors.
Although the mechanism of enhanced transfection efficiency by US is not yet fully understood, cavitation is an important event that leads to modification of the cell membrane and acoustically induced transfection. Cavitation refers to the formation and disruption of microbubbles of gas in acoustic fields, 49 which hypothetically increases cell membrane permeability and allows the uptake of foreign DNA. However, the mechanical bioeffects of US seen in vitro can be difficult to duplicate under in vivo conditions because cavitation phenomena seem to be diminished in living animals. Our previous study revealed that US irradiation under optimized conditions enhanced gene expression of LacZ plasmid DNA in the tumor of mice after intravenous injection of the PEG engrafted cationized dextran-plasmid DNA complex. 45 Based on those results, these optimized conditions (intensity of 2 W/cm 2 , the frequency of 3 MHz, 10% duty cycle, 2 min exposure time, and 120 min time interval of US irradiation) were applied in this study in order to achieve the maximum level of gene expression and a minimum of side effects. However, no side effects were observed during application of US under optimized conditions. Significantly tumor growth suppression was observed under the optimum pressure of the plane transducer US used in this study (0.8 Mpa pressure amplitude of 3 MHz US). The main mechanism of enhanced gene expression under the optimized conditions of US applied in this study might be due to cavitation phenomena.
The low efficiencies make potential application in vivo improbable and even make in vitro experiments difficult. Therefore, experiments were conducted in an attempt to increase the transfection efficiency of acoustically induced transfection for possible application in vivo as an effective means of gene therapy. It was hypothesized that this goal of high transfection efficiency would be achieved by incorporating DNA into microbubbles. These DNAcarrying microbubbles function as an US contrast agent. Contrast agents are widely used in imaging, but until recently they have found little use in ultrasonography. This has changed with the introduction of small microbubbles (typically 3 mm in diameter) which are gas filled bubbles that are usually injected intravenously. Although microbubbles were originally designed simply to improve conventional US scanning, recent discoveries have opened up powerful emerging applications. Additional work is necessary to compare our data with US contrast agents from the view point of enhanced gene expression.
Because angiogenesis is critical for tumor growth, increased angiogenesis coincides with increased tumor cell entry into the blood circulation and thus facilitates metastasis. 50 Therapeutic approaches using angiogenesis inhibitors have received much attention. 51 NK4 also suppresses the angiogenic effects of VEGF and bFGF. 19, 52 On the basis of the bifunctional characteristics of NK4 for targeting both tumor angiogenesis and HGFmediated invasion, it is expected that NK4 can function as a bioactive molecule effective for tumor therapy. Our previuos study revealed that the injection of cationized gelatin microspheres incorporating NK4 plasmid DNA significantly inhibited angiogenesis in tumor tissue while increased the number of apoptotic tumor cells. 53 These findings are consistent with previous studies in which angiogenesis inhibitors suppressed the tumor growth through increasing apoptosis of tumor cells. 54, 55 Thus, it is possible that NK4 suppresses primary tumor growth mainly through inhibition of tumor angiogenesis.
Taken together, the combination of complexation by the PEG engrafted cationized dextran with local US is a promising way of improving the transfection efficacy of plasmid DNA in the targeted organ.
